ArticleFundamental & clinical pharmacology2019

Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases.

Gincy George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.